{"id":"W4295138766","doi":"10.1016/j.jaci.2022.08.027","title":"Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria","year":2022,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"Novartis Pharma; LEO Pharma; Regeneron Pharmaceuticals; Sanofi; Genentech; Amgen","keywords":"Medicine; Placebo; Adverse effect; Randomized controlled trial; Internal medicine; Gastroenterology; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006037026,0.0001211237,0.0005032858,0.0001470289,0.0001770609,0.00001261725,0.00008717963,0.0002239752,0.0001937434],"category_scores_gemma":[0.0003782981,0.00009911371,0.0001152094,0.0001532364,0.0003666422,0.00005633775,0.0001270963,0.001570995,0.00000174457],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001215783,"about_ca_system_score_gemma":0.0004821458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008847663,"about_ca_topic_score_gemma":0.00002007205,"domain_scores_codex":[0.998171,0.0001982888,0.001062325,0.000196849,0.0001333881,0.0002380935],"domain_scores_gemma":[0.9987131,0.0006721418,0.0002868007,0.0001312376,0.00006913858,0.00012757],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.08769043,0.01875338,0.04446227,0.00008847375,0.06608899,0.04192024,0.004352458,0.001124942,0.5483782,0.03248455,0.001544525,0.1531116],"study_design_scores_gemma":[0.05736227,0.02374535,0.7814494,0.0006703376,0.003172113,0.1060091,0.001851298,0.001595916,0.0004250328,0.00306718,0.02007539,0.0005766568],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895602,0.005196772,0.00004123551,0.004128395,0.0004401786,0.0001382926,0.000003193356,0.00001036801,0.0004813553],"genre_scores_gemma":[0.9934827,0.005559488,0.0004070029,0.0002032615,0.0001834273,0.00000250722,0.000004990889,0.0000128675,0.0001437675],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7369871,"threshold_uncertainty_score":0.682528,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01926779695165407,"score_gpt":0.3031378741892569,"score_spread":0.2838700772376028,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}